Average Co-Inventor Count = 3.75
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Portola Pharmaceuticals, Inc. (11 from 70 patents)
2. Pliant Therapeutics, Inc. (3 from 15 patents)
3. Millennium Pharmaceuticals Limited (1 from 850 patents)
4. Alexion Pharmaceuticals, Inc. (1 from 196 patents)
5. Millenium Pharmaceuticals, Inc. (1 from 36 patents)
6. The Cbr Institute for Biomedical Research, Inc. (1 from 10 patents)
7. Cbr, Inc. (1 from 2 patents)
18 patents:
1. 12134642 - Antibodies binding to α7β1 integrin antibodies and compositions thereof
2. 11839646 - Antidotes for factor Xa inhibitors and methods of using the same
3. 11673887 - N-acyl amino acid compounds and methods of use
4. 10675335 - Antidotes for factor Xa inhibitors and methods of using the same
5. 10604520 - N-acyl amino acid compounds and methods of use
6. 9388401 - Antidotes for factor Xa inhibitors and methods of using the same
7. 9062298 - Antidotes for factor XA inhibitors and methods of using the same
8. 8946219 - Combination therapy with a compound acting as a platelet ADP receptor inhibitor
9. 8889129 - Antidotes for factor Xa inhibitors and methods of using the same
10. 8470357 - Methods of treatment with Syk inhibitors
11. 8455441 - Antidotes for factor Xa inhibitors and methods of using the same
12. 8455440 - Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor
13. 8153590 - Antidotes for factor Xa inhibitors and methods of using the same
14. 8057815 - Methods of treatment with Syk inhibitors
15. 7785891 - Device and methods for identifying and treating aspirin non-responsive patients